Ownership as of February 10, 2023. Ten largest shareholders.
| Name | Series A shares | Series B shares | Share capital % | Voting rights % |
|---|---|---|---|---|
| ANNWALL & ROTHSCHILD INVESTMENTS AB | 377 736 | 510 478 | 8.09 | 29.31 |
| SIX SIS AG, W8IMY | 0 | 1 194 861 | 10.64 | 8.17 |
| FJÄRDE AP-FONDEN | 0 | 1 120 000 | 9.98 | 7.66 |
| SWEDBANK ROBUR NY TEKNIK BTI | 0 | 540 000 | 4.81 | 3.69 |
| AMF AKTIEFOND SMÅBOLAG | 0 | 501 585 | 4.47 | 3.43 |
| TREDJE AP-FONDEN | 0 | 501 579 | 4.47 | 3.43 |
| SKANDINAVISKA ENSKILDA BANKEN AB, W8IMY | 0 | 347 673 | 3.10 | 2.38 |
| ÅLANDSBANKEN ABP | 0 | 331 390 | 2.95 | 2.27 |
| UNIONEN | 0 | 322 196 | 2.87 | 2.20 |
| DANGOOR, DAVID | 0 | 306 421 | 2.73 | 2.10 |
| Sub-total | 377 736 | 5 676 183 | 54.11 | 64.64 |
| Other shareholders | 0 | 5 172 265 | 45.89 | 35.36 |
| Total | 377 736 | 10 848 448 | 100.00 | 100.00 |
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.